Pharmaceutical companies are working hard to keep up with leading firms like Eli Lilly and Novo Nordisk to improve the patient experience with weight-loss medications.
The significant popularity of new weight-loss drugs often overshadows some negative aspects. These include the inconvenience of weekly injections and unpleasant gastrointestinal side effects, as well as concerns about muscle and bone loss.
This situation is prompting a competitive push among drug makers to develop improved alternatives.
Trump Administration Seeks Appeal in Vaccine Panel Ruling 
The Complex Decisions Surrounding Early Retirement 
Tyler Mane Raises Awareness with Male Breast Cancer Diagnosis 
Elevated Mortality Risks for Divorcees and Widows 
Routine Surgery Unveils Unexpected Pregnancy for UK Woman 
A Mother’s Journey: From Unexpected Diagnosis to Life-Saving Transplant